PD Dr. med. habil. Anne Hilgendorff
Group Leader Mechanisms of Neonatal Chronic Lung Disease“Chronic lung disease is the most prevalent complication following at-risk birth. Our aim is a profound understanding of its pathophysiology to enable the development of new diagnostic tools and individual treatment strategies.”
“Chronic lung disease is the most prevalent complication following at-risk birth. Our aim is a profound understanding of its pathophysiology to enable the development of new diagnostic tools and individual treatment strategies.”
Academic career and research areas
Anne Hilgendorff is a physician scientist with a strong clinical background and a longstanding scientific interest in chronic lung disease of the developing and the diseased adult lung. Her establishment and leadership of the AIRR (Attention to Infants @ Respiratory Risks, DRKS00004600) cohort in which preterm infants are deeply phenotyped with the aim to identify disease characteristics using novel approaches, crossfertilized her work to implement and lead the lung repository ‘CPC-M bioArchive’ as a platform of the German Center for Lung Research in Munich.
Her work is integrated in large translational consortia including the National Genome Network (NGFN) and the German Center for Lung Research (DZL) highlighted by her leadership of the double-headed disease area ‘Diffuse Parenchymal Lung Disease’. Her clinical work resulted in the foundation of the Comprehensive Developmental Care Center (CDeCLMU) at the LMU Hospital in Munich that she is leading as a director.
Skills
Neonatology Chronic Lung Diseases Lung Development Biomarker Discovery Diagnostic Tool Development Preclinical Studies Translation
Professional Background
Director of the Center for Comprehensive Developmental Care (CDeCLMU), LMU Hospital, Munich, Germany
Head of the neonatal ‘AIRR’ cohort and study (Attention to Infants @ Respiratory Risks, DRKS00004600)
Coordinating Head of the CPC-M bioArchive (DZL – German Center for Lung Research)
Scientific Coordinator of the double-headed Disease Area Diffuse Parenchymal Lung Disease (DPLD) in the German Center for Lung Research (DZL)
Young Investigator Group Leader ‘Molecular Mechanisms of Neonatal Chronic Lung Disease’, CPC/LHI, HMGU, Munich, Germany
Honors and Recognitions
Advisory Board Member of EU Projects and the Helmholtz Leadership Academy
Associate Editor, American Journal of Physiology – Lung Cellular and Molecular Physiology
Associate Editor, Frontiers in Medicine, section Pulmonary Medicine
